These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1919655)

  • 1. Cyclophosphamide plus epidoxorubicin and 5-fluorouracil with folinic acid as a novel treatment in metastatic breast cancer: preliminary results of a phase II study.
    Palmeri S; Gebbia V; Russo A; Gebbia N; Meli M; Rausa L
    J Chemother; 1991 Jun; 3(3):176-9. PubMed ID: 1919655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
    Stöger H; Bauernhofer T; Kasparek AK; Schmid M; Moser R; Ploner F; Derstvenscheg E; Kuss I; Wilders-Truschnig M; Steindorfer P
    Cancer Chemother Pharmacol; 1994; 34(1):75-8. PubMed ID: 8174206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Romito S; Gebbia V; Pacilio G; Giotta F; Testa A; Pezzella G; Durini E; Agostara B; Cariello S
    Br J Cancer; 1995 Nov; 72(5):1245-50. PubMed ID: 7577476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma.
    Gebbia V; Testa A; Valenza R; Cipolla C; Amato C; Latteri M; Gebbia N; Florena M
    Anticancer Res; 1993; 13(1):141-4. PubMed ID: 8386492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma.
    Callari A; Gebbia V; Testa A; Cusimano MP; Cipolla C; Amato C; Cannata G; Latteri MA; Garascia C; Gebbia N
    Acta Oncol; 1994; 33(8):925-9. PubMed ID: 7529516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results.
    Marini G; Marpicati P; Zaniboni A; Cervi GC; Gorni F; Simoncini E
    Chemioterapia; 1985 Apr; 4(2):135-8. PubMed ID: 3874000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
    Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
    Br J Cancer; 2001 Sep; 85(6):798-802. PubMed ID: 11556827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: preliminary results.
    Zaniboni A; Simoncini E; Marpicati P; Montini E; Ferrari V; Ferragni A; Boari L; Marini G
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1151-5. PubMed ID: 2788577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results.
    Pacini P; Rinaldini M; Algeri R; Guarneri A; Tucci E; Barsanti G; Neri B; Bastiani P; Marzano S; Fallai C
    Eur J Cancer; 2000 May; 36(8):966-75. PubMed ID: 10885599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
    Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of mitoxantrone plus cyclophosphamide and 5-fluorouracil in modulation with levo-folinate for advanced breast cancer patients.
    Leonardi V; Meli M; Palmeri S; Russo A; Rini GB; Peralta S; Rausa L
    J Chemother; 1995 Apr; 7(2):160-6. PubMed ID: 7545224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancer.
    Pronzato P; Amoroso D; Ardizzoni A; Bertelli G; Canobbio L; Conte PF; Cusimano MP; Fusco V; Gulisano M; Lionetto R
    Am J Clin Oncol; 1987 Oct; 10(5):404-6. PubMed ID: 3310605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
    Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.
    Francini G; Petrioli R; Aquino A; Gonnelli S
    Cancer Chemother Pharmacol; 1993; 32(5):359-64. PubMed ID: 7687933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U; Harstrick A; Wilke H; Seeber S
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
    van der Wall E; Rutgers EJ; Holtkamp MJ; Baars JW; Schornagel JH; Peterse JL; Beijnen JH; Rodenhuis S
    Br J Cancer; 1996 May; 73(9):1080-5. PubMed ID: 8624267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.